comparemela.com

Latest Breaking News On - Theravance inc - Page 1 : comparemela.com

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Ashleigh-barreto
Michael-faerm
Mark-rothera
Theravance-inc
Viracta-therapeutics-inc
Stanford-university
Regeneron-pharmaceuticals
Harvard-business-school
Harpoon-therapeutics-inc
Artiva-biotherapeutics-inc
Merrill-lynch
Head-of-investor-relations-corporate-communications

Interview with the Chairman and CEO: Theravance Biopharma Inc. (NASDAQ:TBPH)

Interview with the Chairman and CEO: Theravance Biopharma Inc. (NASDAQ:TBPH)
twst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from twst.com Daily Mail and Mail on Sunday newspapers.

California
United-states
Ricke-winningham
Oncomed-pharmaceuticals-inc
Theravance-biopharma-inc
California-life-sciences-association
California-healthcare-institute
Jazz-pharmaceuticals
Nasdaq
Biotechnology-industry-organization
Southern-illinois-university

THRX Stock Price | Theseus Pharmaceuticals Inc. Stock Quote (U.S.: Nasdaq)

THRX | Complete Theseus Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

London
City-of
United-kingdom
Canada
Japan
Canadian
Japanese
Etby-tomi-kilgore
Etby-marketwatch
Etby-ed-ballard
Etby-wallace-witkowski
Breo-ellipta

Comparing Innoviva (NASDAQ:INVA) & Ocular Therapeutix (NASDAQ:OCUL)

Ocular Therapeutix (NASDAQ:OCUL – Free Report) and Innoviva (NASDAQ:INVA – Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations. Risk & Volatility Ocular Therapeutix has a beta of 1.22, […]

Massachusetts
United-states
California
Bedford
Glaxo-group
Regeneron-pharmaceuticals-inc
Innoviva-inc
Affamed-therapeutics
Ocular-therapeutix-inc
Theravance-inc
Ocular-therapeutix

Cytomegalovirus Infection Clinical Trial Pipeline Insights | 15+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space |

Cytomegalovirus Infection Clinical Trial Pipeline Insights | 15+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.

Sandeep-joshi
Chiesi-farmaceutici
Merck-sharp-dohme
Key-companies
Market-research
Boehringer-ingelheim
Glaxosmithkline
Theravance-inc
Route-of-administration
Pfizer
Healthcare-services
University-collaborations-licensing-partnering-analysis
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.